[The clinical pharmacology of a new specific adrenergic beta bronchodilator].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000402:Airway Obstruction / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000814:Aniline Compounds / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D004562:Electrocardiography; D004983:Ethanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010100:Oxygen / Q000097:blood; D010108:Oxyhemoglobins / Q000032:analysis; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D000814:Aniline Compounds; D001993:Bronchodilator Agents; D004983:Ethanolamines; D010108:Oxyhemoglobins; D002245:Carbon Dioxide; D010100:Oxygen
Untersuchungen zur klinischen Pharmakologie eines neuen spezifisch-adrenergischen beta2-Bronchodilators